Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence.

Algorithms Asthma / diagnosis Evidence-Based Practice Humans Practice Guidelines as Topic Rhinitis, Allergic / diagnosis
Allergic Rhinitis and Its Impact on Asthma Allergic rhinitis Development and Evaluation Grading of Recommendations Assessment guidelines real-world evidence

Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
01 2020
Historique:
received: 01 04 2019
revised: 07 05 2019
accepted: 12 06 2019
pubmed: 20 10 2019
medline: 28 7 2020
entrez: 20 10 2019
Statut: ppublish

Résumé

The selection of pharmacotherapy for patients with allergic rhinitis aims to control the disease and depends on many factors. Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidelines have considerably improved the treatment of allergic rhinitis. However, there is an increasing trend toward use of real-world evidence to inform clinical practice, especially because randomized controlled trials are often limited with regard to the applicability of results. The Contre les Maladies Chroniques pour un Vieillissement Actif (MACVIA) algorithm has proposed an allergic rhinitis treatment by a consensus group. This simple algorithm can be used to step up or step down allergic rhinitis treatment. Next-generation guidelines for the pharmacologic treatment of allergic rhinitis were developed by using existing GRADE-based guidelines for the disease, real-world evidence provided by mobile technology, and additive studies (allergen chamber studies) to refine the MACVIA algorithm.

Identifiants

DOI: 10.1016/j.jaci.2019.06.049 PMID: 31627910
pubmed: 31627910
pii: S0091-6749(19)31187-X
doi: 10.1016/j.jaci.2019.06.049
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

70-80.e3

Subventions

Organisme : Medical Research Council
ID : G1000758
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2019 American Academy of Allergy, Asthma & Immunology. All rights reserved.

Auteurs

Jean Bousquet (J)

MACVIA-France, Fondation Partenariale FMC VIA-LR, Montpellier, France; VIMA, INSERM U 1168, VIMA: Ageing and chronic diseases Epidemiological and public health approaches, Villejuif, France, Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, Euforea, Brussels, Belgium and Charité, Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Comprehensive Allergy Center, Department of Dermatology and Allergy, Berlin, Germany. Electronic address: jean.bousquet@orange.fr.

Holger J Schünemann (HJ)

Department of Health Research Methods, Evidence, and Impact, Division of Immunology and Allergy, McMaster University, Hamilton, Ontario, Canada.

Akdis Togias (A)

Division of Allergy, Immunology, and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.

Claus Bachert (C)

Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.

Martina Erhola (M)

National Institute for Health and Welfare, Helsinki, Finland.

Peter W Hellings (PW)

Department of Otorhinolaryngology, University Hospitals Leuven, and Academic Medical Center, University of Amsterdam, The Netherlands, and Euforea, Brussels, Belgium.

Ludger Klimek (L)

Center for Rhinology and Allergology, Wiesbaden, Germany.

Oliver Pfaar (O)

Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.

Dana Wallace (D)

Nova Southeastern University, Fort Lauderdale, Fla.

Ignacio Ansotegui (I)

Department of Allergy and Immunology, Hospital Quirónsalud Bizkaia, Erandio, Spain.

Ioana Agache (I)

Faculty of Medicine, Transylvania University, Brasov, Romania.

Anna Bedbrook (A)

MACVIA-France, Fondation Partenariale FMC VIA-LR, Montpellier, France.

Karl-Christian Bergmann (KC)

Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Uniersität zu Berlin and Berlin Institute of Health, Comprehensive Allergy-Centre, Department of Dermatology and Allergy, member of GA(2)LEN, Berlin, Germany.

Mike Bewick (M)

iQ4U Consultants, London, United Kingdom.

Philippe Bonniaud (P)

CHU Dijon, Dijon, France.

Sinthia Bosnic-Anticevich (S)

Woolcock Institute of Medical Research, University of Sydney and Woolcock Emphysema Centre and Sydney Local Health District, Glebe, Australia.

Isabelle Bossé (I)

Allergist, La Rochelle, France.

Jacques Bouchard (J)

Laval University, Quebec City, Quebec, Canada.

Louis-Philippe Boulet (LP)

Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.

Jan Brozek (J)

Department of Health Research Methods, Evidence, and Impact, Division of Immunology and Allergy, McMaster University, Hamilton, Ontario, Canada.

Guy Brusselle (G)

Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.

Moises A Calderon (MA)

Imperial College London-National Heart and Lung Institute, Royal Brompton Hospital NHS, London, United Kingdom.

Walter G Canonica (WG)

Personalized Medicine Clinic Asthma & Allergy, Humanitas University, Humanitas Research Hospital, Rozzano, Milan, Italy.

Luis Caraballo (L)

Institute for Immunological Research, University of Cartagena, Campus de Zaragocilla, Edificio Biblioteca Primer Piso, and the Foundation for the Development of Medical and Biological Sciences (Fundemeb), Cartagena, Colombia.

Vicky Cardona (V)

Allergy Section, Department of Internal Medicine, Hospital Vall d'Hebron & ARADyAL research network, Barcelona, Spain.

Thomas Casale (T)

the Division of Allergy/Immunology, University of South Florida, Tampa, Fla.

Lorenzo Cecchi (L)

SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy.

Derek K Chu (DK)

Department of Health Research Methods, Evidence, and Impact, Division of Immunology and Allergy, McMaster University, Hamilton, Ontario, Canada.

Elisio M Costa (EM)

UCIBIO, REQUIMTE, Faculty of Pharmacy, and Competence Center on Active and Healthy Ageing of University of Porto (AgeUPNetWork), University of Porto, Porto, Portugal.

Alvaro A Cruz (AA)

ProAR-Nucleo de Excelencia em Asma, Federal University of Bahia, and the WHO GARD Planning Group, Bahia, Brazil.

Wienczyslawa Czarlewski (W)

Medical Consulting Czarlewski, Levallois, France.

Gennaro D'Amato (G)

Division of Respiratory and Allergic Diseases, Hospital "A Cardarelli", University of Naples Federico II, Naples, Italy.

Philippe Devillier (P)

UPRES EA220, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France; Allergy and Clinical Immunology Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Mark Dykewicz (M)

Section of Allergy and Immunology, Saint Louis University School of Medicine, St Louis, Mo.

Motohiro Ebisawa (M)

Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan.

Jean-Louis Fauquert (JL)

Unité de pneumo-allergologie de l'enfant, pôle pédiatrique Pr-Labbé, CHU de Clermont-Ferrand-Estaing, Clermont-Ferrand, France.

Wytske J Fokkens (WJ)

Department of Otorhinolaryngology, Amsterdam University Medical Centres, AMC, Amsterdam, The Netherlands.

Joao A Fonseca (JA)

CINTESIS, Center for Research in Health Technology and Information Systems, Faculdade de Medicina da Universidade do Porto, and Medida, Porto, Portugal.

Jean-François Fontaine (JF)

Allergist, Reims, France.

Bilun Gemicioglu (B)

Department of Pulmonary Diseases, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Turkey.

Roy Gerth van Wijk (RG)

Department of Internal Medicine, section of Allergology, Erasmus MC, Rotterdam, The Netherlands.

Tari Haahtela (T)

Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.

Susanne Halken (S)

Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.

Despo Ierodiakonou (D)

Department of Social Medicine, Faculty of Medicine, University of Crete and International Primary Care Respiratory Group, Crete, Greece.

Tomohisa Iinuma (T)

Department of Otorhinolaryngology, Chiba University Hospital, Chiba, Japan.

Juan-Carlos Ivancevich (JC)

Servicio de Alergia e Immunologia, Clinica Santa Isabel, Buenos Aires, Argentina.

Marek Jutel (M)

Department of Clinical Immunology, Wrocław Medical University, Wroclaw, Poland.

Igor Kaidashev (I)

Ukrainina Medical Stomatological Academy, Poltava, Ukraine.

Musa Khaitov (M)

National Research Center, Institute of Immunology, Federal Medicobiological Agency, Laboratory of Molecular immunology, Moscow, Russia.

Omer Kalayci (O)

Pediatric Allergy and Asthma Unit, Hacettepe University School of Medicine, Ankara, Turkey.

Jorg Kleine Tebbe (J)

Allergy & Asthma Center Westend, Outpatient & Clinical Research Center, Berlin, Germany.

Marek L Kowalski (ML)

Department of Immunology and Allergy, Healthy Ageing Research Center, Medical University of Lodz, Lodz, Poland.

Piotr Kuna (P)

Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.

Violeta Kvedariene (V)

Institute of Biomedical Sciences, Department of Pathology, Faculty of Medicine, Vilnius University and Institute of Clinical medicine, Clinic of Chest diseases and Allergology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

Stefania La Grutta (S)

Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy.

Désirée Larenas-Linnemann (D)

Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, Mexico City, Mexico.

Susanne Lau (S)

Department of Paediatric Pneumology, Immunology and Intensive Care, Charité Universitätsmedizin, Berlin, Germany.

Daniel Laune (D)

KYomed INNOV, Montpellier, France.

Lan Le (L)

University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.

Philipp Lieberman (P)

Departments of Internal Medicine and Pediatrics (Divisions of Allergy and Immunology), University of Tennessee College of Medicine, Germantown, Tenn.

Karin C Lodrup Carlsen (KC)

Oslo University Hospital, Department of Paediatrics, Oslo, and University of Oslo, Faculty of Medicine, Institute of Clinical Medicine, Oslo, Norway.

Olga Lourenço (O)

Faculty of Health Sciences and CICS-UBI, Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.

Gert Marien (G)

Euforea, Brussels, Belgium.

Pedro Carreiro-Martins (P)

Hospital de Dona Estefânia, Centro Hospitalar de Lisboa Central, EPE, Lisbon, and Nova Medical School, CEDOC, Integrated Pathophysiological Mechanisms Research Group, Lisbon, Portugal.

Erik Melén (E)

Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Enrica Menditto (E)

CIRFF, Center of Pharmacoeconomics, University of Naples Federico II, Naples, Italy.

Hugo Neffen (H)

Center of Allergy, Immunology and Respiratory Diseases, Santa Fe, and the Center for Allergy and Immunology, Santa Fe, Argentina.

Gregoire Mercier (G)

Unité Médico-Economie, Département de l'Information Médicale, University Hospital, Montpellier, France.

Ralph Mosgues (R)

Institute of Medical Statistics, and Computational Biology, Medical Faculty, University of Cologne, and Clinical Research International, Hamburg, Germany.

Joaquim Mullol (J)

Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, and Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.

Antonella Muraro (A)

Food Allergy Referral Centre Veneto Region, Department of Women and Child Health, Padua General University Hospital, Padua, Italy.

Leyla Namazova (L)

Scientific Centre of Children's Health under the MoH, Moscow, and Russian National Research Medical University named Pirogov, Moscow, Russia.

Ettore Novellino (E)

Department of Pharmacy of University of Naples Federico II, Naples, Italy.

Robyn O'Hehir (R)

Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, and the Department of Immunology, Monash University, Melbourne, Australia.

Yoshitaka Okamoto (Y)

Department of Otorhinolaryngology, Chiba University Hospital, Chiba, Japan.

Ken Ohta (K)

National Hospital Organization, Tokyo National Hospital, Tokyo, Japan.

Hae Sim Park (HS)

Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, South Korea.

Petr Panzner (P)

Department of Immunology and Allergology, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic.

Giovanni Passalacqua (G)

Allergy and Respiratory Diseases, Ospedale Policlino San Martino-University of Genoa, Genoa, Italy.

Nhan Pham-Thi (N)

Allergy Department, Pasteur Institute, Paris, France.

David Price (D)

Observational and Pragmatic Research Institute, Singapore.

Graham Roberts (G)

David Hide Centre, St Mary's Hospital, Isle of Wight, and University of Southampton, Southampton, United Kingdom.

Nicolas Roche (N)

Pneumologie et Soins Intensifs Respiratoires, Hôpitaux Universitaires Paris, and Hôpital Cochin, Paris, France.

Christine Rolland (C)

Association Asthme et Allergie, Paris, France.

Nelson Rosario (N)

Hospital de Clinicas, University of Parana, Parana, Brazil.

Dermot Ryan (D)

Allergy and Respiratory Research Group, University of Edinburgh, Edinburgh, United Kingdom.

Boleslaw Samolinski (B)

Department of Prevention of Envinronmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.

Mario Sanchez-Borges (M)

Allergy and Clinical Immunology Department, Centro Medico-Docente La Trinidad, Caracas, Venezuela.

Glenis K Scadding (GK)

Royal National TNE Hospital, University College London, London, United Kingdom.

Mohamed H Shamji (MH)

Immunomodulation and Tolerance Group and Allergy and Clinical Immunology, Imperial College London, London, United Kingdom.

Aziz Sheikh (A)

Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom.

Ana-Maria Todo Bom (AT)

Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

Sanna Toppila-Salmi (S)

Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Ioana Tsiligianni (I)

Department of Social Medicine, Faculty of Medicine, University of Crete and International Primary Care Respiratory Group, Crete, Greece.

Marylin Valentin-Rostan (M)

Allergist, Montevideo, Uruguay.

Arunas Valiulis (A)

Vilnius University Institute of Clinical Medicine, Clinic of Children's Diseases, and Institute of Health Sciences, Department of Public Health, Vilnius, Mexico, and the European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium.

Erkka Valovirta (E)

Department of Lung Diseases and Clinical Immunology, University of Turku and Terveystalo Allergy Clinic, Turku, Finland.

Maria-Teresa Ventura (MT)

University of Bari Medical School, Unit of Geriatric Immunoallergology, Bari, Italy.

Samantha Walker (S)

Asthma UK, London, United Kingdom.

Susan Waserman (S)

Department of Medicine, Clinical Immunology and Allergy, McMaster University, Hamilton, Ontario, Canada.

Arzu Yorgancioglu (A)

Department of Pulmonary Diseases, Celal Bayar University, Faculty of Medicine, Manisa, Turkey.

Torsten Zuberbier (T)

Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Uniersität zu Berlin and Berlin Institute of Health, Comprehensive Allergy-Centre, Department of Dermatology and Allergy, member of GA(2)LEN, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Sciences de l'information › Méthodologies informatiques › Algorithmes › Next-generation Allergic Rhinitis and Its...
questionsmedicales.fr › Maladies du système immunitaire › Hypersensibilité › Hypersensibilité immédiate › Hypersensibilité respiratoire › Asthme › Next-generation Allergic Rhinitis and Its...
questionsmedicales.fr › Professions de santé › Pratique factuelle › Next-generation Allergic Rhinitis and Its...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Next-generation Allergic Rhinitis and Its...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Assurance de la qualité des soins de santé › Recommandations comme sujet › Guides de bonnes pratiques cliniques comme sujet › Next-generation Allergic Rhinitis and Its...
questionsmedicales.fr › Maladies du système immunitaire › Hypersensibilité › Hypersensibilité immédiate › Hypersensibilité respiratoire › Rhinite allergique › Next-generation Allergic Rhinitis and Its...